Iradimed (IRMD) EBT Growth (5y) (2018 - 2026)
Iradimed (IRMD) EBT Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.97% |
| Mar 31, 2026 | 34.40% |
| Dec 31, 2025 | 63.61% |
| Sep 30, 2025 | 55.83% |
| Jun 30, 2025 | 35.20% |
| Mar 31, 2025 | 48.05% |
| Dec 31, 2024 | 21.93% |
| Sep 30, 2024 | 19.54% |
| Jun 30, 2024 | 20.64% |
| Mar 31, 2024 | 26.69% |
| Dec 31, 2023 | 24.81% |
| Sep 30, 2023 | 33.87% |
| Jun 30, 2023 | 25.48% |
| Mar 31, 2023 | 31.00% |
| Dec 31, 2022 | 35.45% |
| Sep 30, 2022 | 79.92% |
| Jun 30, 2022 | 64.34% |
| Mar 31, 2022 | 75.50% |
| Dec 31, 2021 | 15.50% |
| Sep 30, 2021 | 3.62% |